The German Cardiometabolic Cost Database - A methodological approach to assess cost data for modelling cost-effectiveness of treatment regimes for patients with multiple cardiometabolic risk factors

被引：0
|
作者：
Fuchs, S. M.
Klauss, V
Dieterle, C.
Wasem, J.
Aidelsburger, P.
机构：
[1] Carem GmbH, Sauerlach, Germany
[2] Univ Munich, Munich, Germany
[3] Univ Duisburg Essen, Essen, Germany
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63691-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A360 / A360
页数：1
相关论文
共 50 条
  • [21] Incorporating Severity and Risk as Factors to the Fardal Cost-Effectiveness Model to Create a Cost-Benefit Model for Periodontal Treatment
    Martin, John A.
    Fardal, Oystein
    Page, Roy C.
    Loeb, Carl F.
    Kaye, Elizabeth Krall
    Garcia, Raul I.
    Linden, Gerard J.
    JOURNAL OF PERIODONTOLOGY, 2014, 85 (03) : E31 - E39
  • [22] Cost-effectiveness analysis of echocardiography in stroke patients without cardiac risk factors
    Saperstein, DS
    Gronseth, GS
    NEUROLOGY, 1998, 50 (04) : A446 - A446
  • [23] Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach
    Nazir, Muhummad Sohaib
    Rodriguez-Guadarrama, Yael
    Rua, Tiago
    Bui, Khan Ha
    Buylova Gola, Anna
    Chiribiri, Amedeo
    McCrone, Paul
    Plein, Sven
    Pennington, Mark
    OPEN HEART, 2022, 9 (01):
  • [24] Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
    Vaidya, Anil
    Joore, Manuela A.
    ten Cate-Hoek, Arina J.
    ten Cate, Hugo
    Severens, Johan L.
    BIOMARKERS IN MEDICINE, 2014, 8 (08) : 989 - 999
  • [25] Cost-effectiveness data to guide treatment decisions for elderly patients: focus on radiotherapy
    Louie, A.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S123 - S123
  • [26] Modelling the cost-effectiveness of Deferasirox (Exjade) in the treatment of iron overloaded myelodysplastic syndrome patients
    Karnon, J.
    Baladi, J. F.
    LEUKEMIA RESEARCH, 2007, 31 : S134 - S134
  • [27] A cost-effectiveness model of screening strategies for amblyopia and risk factors and its application in a German setting
    Gandjour, A
    Schlichtherle, S
    Neugebauer, A
    Rüssmann, W
    Lauterbach, KW
    OPTOMETRY AND VISION SCIENCE, 2003, 80 (03) : 259 - 269
  • [28] TREATMENT IN TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS IN MACEDONIA: DEVELOPMENT OF COST-EFFECTIVENESS ANALYSIS
    Qerimi, V
    Kapedanovska-Nestorovska, A.
    Sterjev, Z.
    Genadieva-Stavric, S.
    Suturkova, L.
    VALUE IN HEALTH, 2017, 20 (09) : A435 - A435
  • [29] Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma
    Blommestein, Hedwig M.
    Franken, Margreet G.
    van Beurden-Tan, Chrissy H. Y.
    Blijlevens, Nicole M. A.
    Huijgens, Peter C.
    Sonneveld, Pieter
    Uyl-de Groot, Carin A.
    Zweegman, Sonja
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [30] Cost-effectiveness analysis of 3 radiation treatment strategies for patients with multiple brain metastases
    Chen, Victor Eric
    Kim, Minchul
    Nelson, Nicolas
    Kim, Inkyu Kevin
    Shi, Wenyin
    NEURO-ONCOLOGY PRACTICE, 2023, 10 (04) : 344 - 351
12345